Duke University Medical Center Patient Treatment

Durham, North Carolina 27710

0 studies enrolling now · 1 studies all time

What they study most

Sickle Cell Disease (SCD)

Studies at this site

• Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC) — Completed